Vivani Medical, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Vivani Medical, Inc.
Artificial Eye Gets Expedited/Breakthrough Designation From US FDA
US FDA has admitted a Second Sight Medical device that the company says could help restore vision to many blind people to its Expedited Access Pathway for swifter review of groundbreaking products.
Execs On The Move, April 2017
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Deals Shaping The Medical Industry, April 2017
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in March 2017.
Australian Bionic Eye Developer Sets Sights To Enter Market By 2020
Australia's Bionic Vision Technologies (BVT) has raised AUS$23m ($18m) from Hong Kong-based investors, China Huarong International Holdings Ltd and State Path Capital Limited, to develop and commercialize its retinal implant device. The technology could reach the market 3-5 years from now.
- Implantable Devices
- Other Names / Subsidiaries
- Nano Precision Medical, Inc.
- Second Sight Medical Products, Inc.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.